A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies

Endocrine Journal

Volumn 48, Issue 2, 2001, Pages 261-268

  Iwasaki, Hiroaki ^a   Sato, Ryuji ^a   Shichiri, Masayoshi ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Cerebellar ataxia; Glutamic acid decarboxylase; Stiff man syndrome; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; UNCLASSIFIED DRUG;

AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CASE REPORT; CEREBELLAR ATAXIA; CLINICAL FEATURE; COMORBIDITY; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LANGERHANS CELL; PANCREAS ISLET; PATHOGENESIS; PHYSICAL EXAMINATION; PURKINJE CELL; STIFF MAN SYNDROME;

EID: 0034985057     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.261     Document Type: Article

References (24)

1. Two isoforms of glutamate decarboxylase: Why?
2. High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma
3. High concentration of γ-aminobutyric acid in pancreatic beta cells
4. Glutamic acid decarboxylase expression in islets and brain
5. The pathogenesis of insulin-dependent diabetes mellitus
6. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus
7. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
8. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
9. Stiff-man syndrome
10. Glutamic acid decarboxylase-gene to antigen to disease
11. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type 1 diabetes mellitus
12. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome
13. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity
14. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy
15. Heterogeneity of autoantibodies in stiff-man syndrome
16. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor
17. Pancreatic β-cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble
18. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus
19. Control of autoimmune diabetes in NOD mice by GD expression or suppression in β cell
20. The clinical significance of an autoimmune response against glutamic acid decarboxylase
21. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
22. Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons
23. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition
24. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus